2021-07-22 02:42:48 GMT2021-07-22 10:42:48(Beijing Time)Xinhua English
A medical worker takes a swab sample from a woman for COVID-19 test at a testing site in Nanjing, east China's Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Ji Chunpeng)
A medical worker takes a swab sample from a woman for COVID-19 test at a testing site in Nanjing, east China's Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Ji Chunpeng)
Medical workers take swab samples from residents for COVID-19 test at a testing site in Nanjing, east China's Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Li Bo)
A medical worker takes a swab sample from a girl for COVID-19 test at a testing site in Nanjing, east China's Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Ji Chunpeng)
People register for COVID-19 test at a testing site in Nanjing, east China's Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Ji Chunpeng)
A medical worker takes a swab sample from an elderly man for COVID-19 test at a testing site in Nanjing, east China's Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Li Bo)
A medical worker takes a swab sample from a man for COVID-19 test at a testing site in Nanjing, east China's Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Ji Chunpeng)
People queue for COVID-19 test at a testing site in Nanjing, east China's Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Li Bo)
A medical worker takes a swab sample from a woman for COVID-19 test at a testing site in Nanjing, east China's Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Ji Chunpeng)
A medical worker takes a swab sample from a woman for COVID-19 test at a testing site in Nanjing, east China's Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Ji Chunpeng)
A medical worker takes a swab sample from a woman for COVID-19 test at a testing site in Nanjing, east China's Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Ji Chunpeng)
Medical workers take swab samples from residents for COVID-19 test at a testing site in Nanjing, east China's Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Li Bo)
A medical worker takes a swab sample from a girl for COVID-19 test at a testing site in Nanjing, east China's Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Ji Chunpeng)
People register for COVID-19 test at a testing site in Nanjing, east China's Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Ji Chunpeng)
A medical worker takes a swab sample from an elderly man for COVID-19 test at a testing site in Nanjing, east China's Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Li Bo)
A medical worker takes a swab sample from a man for COVID-19 test at a testing site in Nanjing, east China's Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Ji Chunpeng)
People queue for COVID-19 test at a testing site in Nanjing, east China's Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Li Bo)
A medical worker takes a swab sample from a woman for COVID-19 test at a testing site in Nanjing, east China's Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Ji Chunpeng)